Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Isolated Follicles Enriched for Centroblasts and Lacking t(14;18)/BCL2 in Lymphoid Tissue: Diagnostic and Clinical Implications.

Nybakken GE, Bala R, Gratzinger D, Jones CD, Zehnder JL, Bangs CD, Cherry A, Warnke RA, Natkunam Y.

PLoS One. 2016 Mar 18;11(3):e0151735. doi: 10.1371/journal.pone.0151735. eCollection 2016.

2.

Quizartinib elicits differential responses that correlate with karyotype and genotype of the leukemic clone.

Nybakken GE, Canaani J, Roy D, Morrissette JD, Watt CD, Shah NP, Smith CC, Bagg A, Carroll M, Perl AE.

Leukemia. 2016 Jun;30(6):1422-5. doi: 10.1038/leu.2015.320. Epub 2015 Nov 20. No abstract available.

3.

The genetic basis and expanding role of molecular analysis in the diagnosis, prognosis, and therapeutic design for myelodysplastic syndromes.

Nybakken GE, Bagg A.

J Mol Diagn. 2014 Mar;16(2):145-58. doi: 10.1016/j.jmoldx.2013.11.005. Epub 2014 Jan 21. Review.

4.

Terminal myeloid differentiation in vivo is induced by FLT3 inhibition in FLT3/ITD AML.

Sexauer A, Perl A, Yang X, Borowitz M, Gocke C, Rajkhowa T, Thiede C, Frattini M, Nybakken GE, Pratz K, Karp J, Smith BD, Levis M.

Blood. 2012 Nov 15;120(20):4205-14. doi: 10.1182/blood-2012-01-402545. Epub 2012 Sep 25.

5.

MITF accurately highlights epidermal melanocytes in atypical intraepidermal melanocytic proliferations.

Nybakken GE, Sargen M, Abraham R, Zhang PJ, Ming M, Xu X.

Am J Dermatopathol. 2013 Feb;35(1):25-9. doi: 10.1097/DAD.0b013e31825666c3.

6.

Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody.

Cherrier MV, Kaufmann B, Nybakken GE, Lok SM, Warren JT, Chen BR, Nelson CA, Kostyuchenko VA, Holdaway HA, Chipman PR, Kuhn RJ, Diamond MS, Rossmann MG, Fremont DH.

EMBO J. 2009 Oct 21;28(20):3269-76. doi: 10.1038/emboj.2009.245. Epub 2009 Aug 27.

7.

Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins.

Lok SM, Kostyuchenko V, Nybakken GE, Holdaway HA, Battisti AJ, Sukupolvi-Petty S, Sedlak D, Fremont DH, Chipman PR, Roehrig JT, Diamond MS, Kuhn RJ, Rossmann MG.

Nat Struct Mol Biol. 2008 Mar;15(3):312-7. doi: 10.1038/nsmb.1382. Epub 2008 Feb 10.

PMID:
18264114
8.

The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection.

Pierson TC, Xu Q, Nelson S, Oliphant T, Nybakken GE, Fremont DH, Diamond MS.

Cell Host Microbe. 2007 Apr 19;1(2):135-45.

9.

Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes.

Sukupolvi-Petty S, Austin SK, Purtha WE, Oliphant T, Nybakken GE, Schlesinger JJ, Roehrig JT, Gromowski GD, Barrett AD, Fremont DH, Diamond MS.

J Virol. 2007 Dec;81(23):12816-26. Epub 2007 Sep 19.

10.

Induction of epitope-specific neutralizing antibodies against West Nile virus.

Oliphant T, Nybakken GE, Austin SK, Xu Q, Bramson J, Loeb M, Throsby M, Fremont DH, Pierson TC, Diamond MS.

J Virol. 2007 Nov;81(21):11828-39. Epub 2007 Aug 22.

11.

Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein.

Oliphant T, Nybakken GE, Engle M, Xu Q, Nelson CA, Sukupolvi-Petty S, Marri A, Lachmi BE, Olshevsky U, Fremont DH, Pierson TC, Diamond MS.

J Virol. 2006 Dec;80(24):12149-59. Epub 2006 Oct 11.

12.

Crystal structure of the West Nile virus envelope glycoprotein.

Nybakken GE, Nelson CA, Chen BR, Diamond MS, Fremont DH.

J Virol. 2006 Dec;80(23):11467-74. Epub 2006 Sep 20.

13.

West Nile virus in complex with the Fab fragment of a neutralizing monoclonal antibody.

Kaufmann B, Nybakken GE, Chipman PR, Zhang W, Diamond MS, Fremont DH, Kuhn RJ, Rossmann MG.

Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12400-4. Epub 2006 Aug 8.

14.

Antibodies against West Nile Virus nonstructural protein NS1 prevent lethal infection through Fc gamma receptor-dependent and -independent mechanisms.

Chung KM, Nybakken GE, Thompson BS, Engle MJ, Marri A, Fremont DH, Diamond MS.

J Virol. 2006 Feb;80(3):1340-51.

15.

Structural basis of West Nile virus neutralization by a therapeutic antibody.

Nybakken GE, Oliphant T, Johnson S, Burke S, Diamond MS, Fremont DH.

Nature. 2005 Sep 29;437(7059):764-9.

PMID:
16193056
16.

Toward the development of peptide nanofilaments and nanoropes as smart materials.

Wagner DE, Phillips CL, Ali WM, Nybakken GE, Crawford ED, Schwab AD, Smith WF, Fairman R.

Proc Natl Acad Sci U S A. 2005 Sep 6;102(36):12656-61. Epub 2005 Aug 29.

17.

Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus.

Oliphant T, Engle M, Nybakken GE, Doane C, Johnson S, Huang L, Gorlatov S, Mehlhop E, Marri A, Chung KM, Ebel GD, Kramer LD, Fremont DH, Diamond MS.

Nat Med. 2005 May;11(5):522-30. Epub 2005 Apr 24.

18.

Test-retest precision of functional magnetic resonance imaging processed with independent component analysis.

Nybakken GE, Quigley MA, Moritz CH, Cordes D, Haughton VM, Meyerand ME.

Neuroradiology. 2002 May;44(5):403-6. Epub 2002 Mar 1.

PMID:
12012124

Supplemental Content

Loading ...
Support Center